Home > Boards > US OTC > Biotechs >

OncoVista Innovative Therapies, Inc. (OVIT)

OVIT RSS Feed
Add OVIT Price Alert      Hide Sticky   Hide Intro
Moderator: sharkgroupsn, gi197845
Search This Board: 
Last Post: 5/18/2019 2:01:58 AM - Followers: 20 - Board type: Free - Posts Today: 0

OncoVista Innovative Therapies, Inc. (OVIT) 

 

Please see the bottom of the iBox for a contrary view on this stock.

 

http://www.oncovista.com/

 

 

Company Information:

OncoVista Innovative Therapies, Inc.
14785 Omicron Drive
Suite 104
San Antonio,, TX 78245

Phone: 210-677-6000

 

CIK:  0001094847

The latest 10Q can be found here: http://filings.issuerdirect.com/data/1094847/000114420411063209/v240119_10q.pdf

Link to clinical trials register: http://www.clinicaltrials.gov/ct2/results?term=cordycepin 

Neither of the two cordycepin studies registered with clinical.trials.gov has been updated for over two years, which is a breach of registration conditions.

 

 

OncoVista Innovative Therapies, Inc., is a bio-pharmaceutical company that claims to be dedicated to providing innovative, safe and efficacious treatments for cancer through the use of biomarkers in order to extend and improve the quality of life for patients.

Based in San Antonio, Texas, OncoVista was incorporated in 2004 and says it utilizes state-of-the-art drug discovery technologies, innovative clinical development and registration strategies as well as emerging technologies to bring to market new, safe and highly effective anti-cancer drugs. Although no such drugs have yet been brought to market, and the "incubator" behind Onco Vista, Technology Innovations, LLC, has a long and inglorious history of transferring monies from its publicly held spin-offs such as Biophan and Natural Nano into private hands.

 

Management: 

http://www.oncovista.com/index.php?option=com_content&task=view&id=67

 

 

Claims made by Onco Vista regarding its Core Capabilities for Accelerated Drug Development

Lipitek International
Well-equipped research labs for chemical synthesis and biological evaluations; GMP manufacturing suite

UT Health Science Center (Prof. Luduena)
Biological evaluation and testing of new anti-mitotics, including tubulin isotype-specific assays

University of Alberta (Prof. Tuszynski)
Molecular modeling, computer simulation of new molecules, molecule design and in silico screening

AAI Oncology (Paris)
Global oncology-focused clinical Contract Research Organization (CRO)

Cancer Therapy & Research Center (CTRC)/Institute for Drug Development (IDD)
In vitro and in vivo capabilities; Phase I/II clinical trials

Other Local Resources (nothing to do with Onco Vista per se: probably included here to give an impression of referred respectability).
Southwest Oncology Group
Southwest Foundation for Biomedical Research

 

 

 

Press Releases:  
http://www.oncovista.com/index.php?option=com_content&task=view&id=91

http://finance.yahoo.com/q/h?s=OVIT.OB+Headlines

 

 

-----------------------

 

 

 

AdnaGen

http://www.adnagen.com/

 

News from AdnaGen site, which is majority owned by OVIT

http://www.adnagen.com/HTML_Dateien/e_news_news.htm

 

OVIT used to own 78% of the issued and outstanding shares of AdnaGen*

 

* On November 2, 2010, OncoVista Innovative Therapies, Inc. (the "Company") entered into a Stock Purchase Agreement with Alere Holdings Bermuda Limited Canon's Court ("Alere Holdings"), whereby the Company sold all of its shares, representing approximately 78.01% of the total issued and outstanding shares, of its majority-owned German operating subsidiary AdnaGen AG ("AdnaGen").   Under the terms of the Stock Purchase Agreement, the Company and the other AdnaGen shareholders agreed to sell their respective shares of AdnaGen, and all AdnaGen related business assets, to Alere Holdings in consideration of: (i) a $10,000,000 up-front;  (ii) $10,000,000 in potential milestone payments contingent upon the achievement of various balance sheet objectives within 24 months; and (iii) up to $63,000,000 in potential milestone payments contingent upon the achievement of various clinical, regulatory and sales objectives within 36 months (collectively, the "Consideration").  The Company is entitled to receive its pro rata portion of approximately 78.01% of all Consideration.http://www.sec.gov/Archives/edgar/data/1094847/000114420410057309/v200923_8k.htm

 

----------------------

  

Filings:

http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001094847&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

 

Share Structure:

Authorized Shares

147,397,390 as of September 30, 2011

 

Outstanding Shares

21,370,725 as of September 30, 2011

 

 

 

 


 

 


 

 

 

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 


 

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 

OVIT
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#618   It's interesting that the ask is at 200.00, gi197845 05/18/19 02:01:58 AM
#617   Almost there sharkgroupsn 05/08/19 05:35:22 PM
#616   Another 200k today!! BigWorm129 05/08/19 04:37:48 PM
#615   I just saw over 200k shares yesterday, which BigWorm129 05/02/19 01:22:56 PM
#614   I saw the volume yesterday, wasn't it like gi197845 05/02/19 01:17:12 PM
#613   Anyone see the volume yesterday? What was that about? BigWorm129 05/02/19 11:08:13 AM
#612   25k shares this morning. BigWorm129 04/25/19 09:55:26 AM
#611   Dead board, dead stock, dead ticker, dead company, gi197845 03/31/19 08:11:15 PM
#610   If that 500k bid wasn’t on CDEL I’d sharkgroupsn 03/20/19 10:27:43 AM
#609   Uh oh, 500 shares sold today, could be gi197845 03/19/19 11:42:23 AM
#608   Well, that's cool, another no volume day. I'm gi197845 03/07/19 05:42:14 PM
#606   Yes, lol and my money has been dead gi197845 02/28/19 01:00:51 PM
#605   I fish a lot. I also like watching BigWorm129 02/27/19 11:16:41 PM
#604   Nothing happens now or ever. gi197845 02/27/19 09:58:45 PM
#603   So what happens now? Zzzzzzzzzzz BigWorm129 02/25/19 11:31:56 PM
#602   Uh oh, another no volume day, so much gi197845 02/25/19 06:05:58 PM
#601   Uh oh, another no volume day, so much gi197845 02/06/19 04:33:39 PM
#600   In my opinion, it's wishful thinking, although history gi197845 01/29/19 05:12:38 PM
#599   gi: sharkgroup seems to be pretty confident of Batermere 01/29/19 05:01:30 PM
#598   Bate, rumor has it that a while ago, gi197845 01/29/19 05:00:31 PM
#597   Wow, several no-volume days. gi197845 01/24/19 05:09:12 PM
#596   Ok, it was not listed that way the gi197845 01/17/19 05:33:29 PM
#595   You mean the Aengus part I assume? That sharkgroupsn 01/17/19 05:22:36 PM
#594   What does this mean? https://www.bloomberg.com/research/stocks/private/snapshot. gi197845 01/17/19 05:08:55 PM
#593   9.5 out of 10. 3 reasons why: #1 sharkgroupsn 01/16/19 06:11:18 PM
#592   How confident are you on a scale of gi197845 01/16/19 05:54:26 PM
#591   Wish I knew when. Haven’t seen 300k volume sharkgroupsn 01/16/19 05:44:50 PM
#590   When will the new reverse shell merger with gi197845 01/16/19 05:35:35 PM
#589   No volume today, what's up with OVIT? gi197845 01/15/19 10:10:28 PM
#588   When will the new reverse shell merger with gi197845 01/14/19 09:23:13 PM
#587   Rather than investors just buying shares of a gi197845 01/11/19 11:12:01 PM
#586   Nice volume today. .10 right around the corner. sharkgroupsn 01/11/19 01:22:19 PM
#585   More sells today on low volume, oopsie. gi197845 01/10/19 06:01:16 PM
#584   More buys then sells yesterday on decent volume FWIW sharkgroupsn 01/10/19 09:25:39 AM
#583   Please explain how would a conflict of interest gi197845 01/08/19 07:16:08 PM
#582   Conflict of interest in this case would be sharkgroupsn 01/08/19 07:00:55 PM
#581   http://biochem.uthscsa.edu/faculty.php?displayID=45 gi197845 01/08/19 06:10:24 PM
#580   Ok, a conflict of interest sounds like a gi197845 01/08/19 06:02:03 PM
#579   Not sure if this has anything to do sharkgroupsn 01/08/19 05:45:12 PM
#578   Wow, let's of sells today... gi197845 01/08/19 05:16:09 PM
#577   Wow, someone bough 1,00 shares of Onco Vista gi197845 01/07/19 01:37:57 PM
#576   Maybe Monday will be the reverse shell merger gi197845 01/05/19 10:05:21 PM
#575   There was no year end announcement of a gi197845 12/31/18 09:39:11 PM
#574   EOY announcement? sharkgroupsn 12/28/18 12:52:15 PM
#573   Oh ya, baby! gi197845 12/26/18 04:30:42 PM
#572   Reverse shell merger is correct. IMO sharkgroupsn 12/19/18 07:56:04 AM
#571   Whoa, more volume today! Could a reverse shell gi197845 12/18/18 09:01:32 PM
#570   Ya, it will be a big win, win, win! gi197845 12/17/18 02:19:45 PM
#569   $1.75 in last big run. biotech2 12/16/18 05:38:48 PM
#568   Nice volume again. Bids stacking sharkgroupsn 12/14/18 05:46:49 PM
PostSubject